These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [The use of lipids in total parenteral nutrition]. Motton G; Burro A Chir Ital; 1994; 46(6):31-5. PubMed ID: 8521538 [TBL] [Abstract][Full Text] [Related]
23. Lipid metabolism of the micropremie. Putet G Clin Perinatol; 2000 Mar; 27(1):57-69, v-vi. PubMed ID: 10690564 [TBL] [Abstract][Full Text] [Related]
26. [Use of MCT-containing fat emulsions in stress conditions]. Jauch KW; Hailer S Beitr Infusionther Klin Ernahr; 1988; 20():145-55. PubMed ID: 3132141 [No Abstract] [Full Text] [Related]
27. American Academy of Pediatrics. Committee on Nutrition. Use of Intravenous fat emulsions in pediatric patients. Pediatrics; 1981 Nov; 68(5):738-43. PubMed ID: 6796933 [No Abstract] [Full Text] [Related]
28. [Fat emulsion in liver injury--risks and advantages]. Rössner S Lakartidningen; 1980 May; 77(21):2000-2. PubMed ID: 6772893 [No Abstract] [Full Text] [Related]
30. [The value of fat emulsions in parenteral feeding of patients in intensive care]. Kuhnigk H Krankenpfl J; 1993 Sep; 31(9):356-8. PubMed ID: 8411955 [No Abstract] [Full Text] [Related]
31. [Metabolic fate and efficacy of intravenously given nutrients: comparison with oral administration (Lipid preparations)]. Tamakuma S; Isoyama T Nihon Rinsho; 1979; 37(8):2949-53. PubMed ID: 117162 [No Abstract] [Full Text] [Related]
32. Should the use of total nutrient admixtures be limited? Mirtallo JM Am J Hosp Pharm; 1994 Nov; 51(22):2831-4. PubMed ID: 7856610 [No Abstract] [Full Text] [Related]
33. Parenteral nutrition in a patient with familial Type IV hypertriglyceridemia: a dilemma. Rapp RP; Donaldson ES; Bivins BA Drug Intell Clin Pharm; 1983 Jun; 17(6):458-60. PubMed ID: 6407811 [TBL] [Abstract][Full Text] [Related]
34. [Lipid emulsions and their effects]. Impieri M; Franceschini L; Briglia R; Giannini S; Defranchi PG; Veneroso A; Belloni E; Pera M Minerva Chir; 1987 Nov; 42(21):1757-9. PubMed ID: 3696438 [No Abstract] [Full Text] [Related]
35. Liver disease after TPN. Freund U Gastroenterology; 1982 Jan; 82(1):164-5. PubMed ID: 6796455 [No Abstract] [Full Text] [Related]
36. [Use of a fat emulsion in a complex of parenteral feeding preparations in experimental intestinal obstruction]. Gitis EI; Fedorova ZP; Fialek VIu; Dziublik RF Fiziol Zh (1978); 1980; 26(5):629-33. PubMed ID: 6775984 [No Abstract] [Full Text] [Related]
37. Reversal of parenteral nutrition-associated liver disease in two infants with short bowel syndrome using parenteral fish oil: implications for future management. Gura KM; Duggan CP; Collier SB; Jennings RW; Folkman J; Bistrian BR; Puder M Pediatrics; 2006 Jul; 118(1):e197-201. PubMed ID: 16818533 [TBL] [Abstract][Full Text] [Related]
38. What is the current role for parenteral lipid emulsions containing omega-3 fatty acids in infants with short bowel syndrome? Diamond IR; Pencharz PB; Wales PW Minerva Pediatr; 2009 Jun; 61(3):263-72. PubMed ID: 19461570 [TBL] [Abstract][Full Text] [Related]
39. Lipid emulsions in the newborn infant. Spear ML Del Med J; 1984 Nov; 56(11):655-7. PubMed ID: 6437884 [No Abstract] [Full Text] [Related]
40. [Serial publication from the Committee on Toxicology Laboratories--Application of parenteral lipid emulsions to therapy for poisonings]. Committee on Toxicology Laboratories Chudoku Kenkyu; 2009 Mar; 22(1):70-4. PubMed ID: 19344064 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]